Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent

K Kusugami1, A Fukatsu, M Tanimoto

  • 1First Department of Internal Medicine, Nagoya University School of Medicine, Japan.

Insights

Elevated local interleukin-6 (IL-6) activity is a key feature of active inflammatory bowel disease (IBD). Macrophages and colonic epithelial cells are the primary sources of this increased IL-6 in active IBD patients.

Area of Science:

  • Gastroenterology
  • Immunology
  • Molecular Biology

Background:

  • Inflammatory bowel disease (IBD) involves chronic inflammation of the digestive tract.
  • Interleukin-6 (IL-6) is a cytokine implicated in inflammatory processes.

Purpose of the Study:

  • To investigate local interleukin-6 (IL-6) activity in colonic tissues of patients with inflammatory bowel disease (IBD).
  • To identify the cellular sources of IL-6 in active IBD.

Main Methods:

  • Culturing of lamina propria mononuclear cells (LPMC) and colonic mucosal tissues.
  • Northern blot analysis for IL-6 messenger RNA detection.
  • Immunofluorescent microscopy for IL-6 protein localization.

Main Results:

  • Active IBD specimens showed significantly higher IL-6 activity compared to controls.
  • IL-6 messenger RNA and protein were detected in LPMC and colonic epithelial cells from active IBD patients.
  • Increased IL-6-producing cells were observed in active IBD mucosal tissues.

Conclusions:

  • Elevated local IL-6 activity is a characteristic feature of active IBD.
  • Macrophages (CD68+ cells) and colonic epithelial cells are major contributors to IL-6 production in active IBD.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...